Source: Annual Congress 2009 - Translational models of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chen, W. Xu, N. Ge, J. Xu (Guangzhou, China). Hemaglutinin (HA) of H5N1 disturbs cAMP-dependent CFTR channel via activation of janus kinase 3. Eur Respir J 2009; 34: Suppl. 53, 4436

Member's Comments

No comment yet.

Related content which might interest you: Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Group V phospholipase A2 (gVPLA2) -induced eosinophil synthesis of LTC4 is independent of mitogen-activated protein kinases (MAPK) activation Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001 FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction Source: Eur Respir J 2010; 36: 1165-1173 Year: 2010 Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries Source: Eur Respir J 2013; 41: 85-95 Year: 2013 Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids Source: Eur Respir J 2011; 37: 933-942 Year: 2011 LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Ventilation-induced activation of the mitogen-activated protein kinase pathway Source: Eur Respir J 2002; 20: 946-956 Year: 2002 c-Jun N-terminal kinase-dependent mechanisms in respiratory disease Source: Eur Respir J 2006; 28: 651-661 Year: 2006 Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs Source: Eur Respir J 2013; 42: 28-41 Year: 2013 Effect of fudosteine on mucin production Source: Eur Respir J 2008; 32: 1195-1202 Year: 2008 Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 160s Year: 2001 The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema Source: Eur Respir J 2005; 25: 849-857 Year: 2005 The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008 Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands Source: Annual Congress 2011 - COPD: human studies Year: 2011 Mitogen activated protein kinase activated protein kinase 2 regulates actin stress fiber formation in ventilator associated lung injury Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Activation of second messenger pathways in alveolar macrophages by endotoxin Source: Eur Respir J 2002; 20: 210-222 Year: 2002 LSC - 2017 - Profibrotic signaling by TGF-ß involves NADPH oxidase 4 dependent activation of tyrosine kinase Src and mitochondrial ROS Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Syk is downstream of ICAM-1 and mediates human rhinovirus (HRV) activation of p38 MAP kinase in airway epithelial cells Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006 The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021